Whether it's cystic fibrosis or ulcerative colitis, we understand the unique nuances of internal medicine trials. Recognizing the need for customized strategies across subspecialties, our team of therapeutically aligned experts take a tailored approach to navigating the complexities of your clinical trial – developing and implementing optimal clinical strategies, and maximizing patient impact. Learn more. https://bit.ly/3Xg3AbX #medicinetrials #clinicaltrials #patientimpact
IQVIA Biotech
Biotechnology Research
Durham, NC 116,207 followers
Supporting biotech companies from innovation to patient impact
About us
IQVIA Biotech is a biotech-specialized CRO delivering flexible clinical development solutions for biotech and emerging biopharma companies. Our clinical solutions are built on 25 years of unmatched experience with therapeutically aligned expertise, uniquely designed to deliver full-service solutions on a global scale.
- Website
-
https://iqviabiotech.com
External link for IQVIA Biotech
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Durham, NC
- Founded
- 1998
Updates
-
Over the past 25 years, IQVIA Biotech has been successfully delivering dermatology clinical trials around the world. With board-certified dermatologists on staff, local regulatory expertise, and accelerated patient recruitment, learn how we’re driving new discoveries in dermatology. https://bit.ly/3z3aVUh #dermatology #clinicaltrials
-
-
The ESMO congress is a unique chance to network with some of the world’s leading oncology professionals – including the experts from IQVIA Biotech and IQVIA! Schedule a meeting today with one of our oncology experts at #ESMO204 https://lnkd.in/eJQ-Mu-D
-
Cardiovascular, Renal and Metabolic (CVRM) health is the fastest expanding disease spectrum globally – and with shared risk factors, understanding patient populations and interconnections is crucial to trial outcomes. With first-hand experience of the unique trial challenges across these three areas, IQVIA Biotech’s CVRM team helps you deliver treatments to patients, faster. Learn more. https://bit.ly/3Z7JoM5 #CVRM #clinicaltrials
-
-
If you missed our recent webinar on how groundbreaking cell and gene therapies (CAGT) are revolutionizing previously untreatable diseases, catch up now with IQVIA Biotech on-demand. You’ll gain critical insights into the dynamic regulatory landscape of CAGT trials and come away with a practical understanding of the questions biotech sponsors should be asking. Watch now. https://lnkd.in/etxDv8jq #CAGT #clinicaltrials
-
Developing successful central nervous system (CNS) drugs is a complex process. But with more than 1,000 CNS clinical trials in the past 10 years, and board-certified neurologists on staff, IQVIA Biotech understands the complexities at every step and across a wide range of indications. Learn more. https://lnkd.in/e5iNtWyA #CNS #drugdevelopment #clinicaltrials
-
-
For biotech companies embarking on clinical trial planning and execution, finding a CRO to help anticipate and navigate the operational complexities of CAGT therapies is critical. IQVIA Biotech’s multidisciplinary Cell and Gene Therapy Study Management team provides end-to-end solutions to streamline your processes and advance your CAGT clinical trial. Discover more. https://bit.ly/4dMZZt0 #CAGT #clinicaltrials
-
-
With 500+ studies in the past 5 years and board-certified oncologists and hematologists on staff, IQVIA Biotech’s oncology clinical trial expertise is second-to-none. Discover how a strong foundation of therapeutic, scientific and operational expertise can make your trial more precise, predictable and efficient. Learn more. https://bit.ly/4cRSYG6 #oncology #clinicaltrials
-
-
Selene Gardea shares her story about how joining IQVIA Biotech has been one of her best career decisions. "When I received the opportunity to join IQVIA Biotech two years ago, it was very unexpected, I was not looking for a change, but since the first approach I had the feeling this would be a good refresh and a reset for my professional career. I am very grateful to IQVIA Biotech for the confidence in my skills and for considering I would be a good asset for the team. Since the beginning my managers made me feel like part of the company and I received a lot of support from my teammates. The onboarding process was amazing, very helpful and different from the ones I received in my previous jobs. Two years later, I still believe joining IQVIA Biotech has been one of the best decisions I have made in my life. I have grown as a leader, I am still learning from my colleagues and I am proud to belong to this important global company." Join IQVIA's global family: Be a catalyst for positive change in healthcare https://bit.ly/3ZoS6pt #Biotech #CareerGrowth #Support #Partnership #WeAreIQVIA #MakingaDifference #Global
-
-
Cell and gene therapy (CAGT) is following a rapid upwards trajectory, but the best methods for post-trial long-term follow-up (LTFU) are still evolving. With the FDA and EMA issuing guidelines for the design and key data elements of required LTFU studies for CAGT, IQVIA Biotech’s Erin Finot, MS, MBA and IQVIA’s Barbara Isquith Arone, MS consider how best to meet them head-on. Read now. https://bit.ly/4dOu4bO #biotech #genetherapy #CAGT #celltherapy #clinicaltrials
-